CADE vs. ABT

Last updated Jun 4, 2026

CADE (Cadence Bancorporation) and ABT (Abbott Laboratories) are both stocks. CADE operates in Banks - Regional (Financial Services), while ABT operates in Medical Devices (Healthcare). At a 0.23 correlation, their price movements are largely independent.

Performance

CADE vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cadence Bancorporation (CADE) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CADE

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

ABT

• 1D: 0.02%
• 1M: -0.63%
• YTD: -29.78%
• 6M: -29.78%
• 1Y: -33.61%
• 3Y*: -3.93%
• 5Y*: -2.65%
• 10Y*: 10.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CADE vs. ABT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CADE Cadence Bancorporation	-0.91%	28.38%	20.36%	24.98%	-14.34%	16.67%	-9.67%	23.07%	-15.28%	10.05%
ABT Abbott Laboratories	-29.78%	12.87%	4.81%	2.26%	-20.68%	30.53%	28.04%	22.08%	29.06%	35.15%

Correlation

The correlation between CADE and ABT is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.23
Correlation (All Time) Calculated using the full available price history since Apr 17, 2017	0.23

Fundamentals

Market Cap CADE : $7.98B ABT : $151.97B
EPS CADE : $2.88 ABT : $3.59
PE Ratio CADE : 14.60 ABT : 24.24
PEG Ratio CADE : 1.23 ABT : 1.51
PS Ratio CADE : 2.89 ABT : 3.37
PB Ratio CADE : 1.31 ABT : 2.30
Total Revenue (TTM) CADE : $2.75B ABT : $45.13B
Gross Profit (TTM) CADE : $1.36B ABT : $25.45B
EBITDA (TTM) CADE : $564.17M ABT : $10.80B

Return for Risk

CADE vs. ABT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABT

ABT Risk / Return Rank: 3
ABT Sharpe Ratio Rank: 1
ABT Sortino Ratio Rank: 3
ABT Omega Ratio Rank: 3
ABT Calmar Ratio Rank: 7
ABT Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CADE vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cadence Bancorporation (CADE) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CADE	ABT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-1.41	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.12	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.44	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.49	—

Drawdowns

Drawdown Indicators

	CADE	ABT	Difference
Max Drawdown Largest peak-to-trough decline	—	-45.66%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-38.99%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-39.64%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-39.64%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-39.64%	—
Current Drawdown Current decline from peak	—	-36.40%	—
Average Drawdown Average peak-to-trough decline	—	-10.83%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	16.86%	—

Volatility

Volatility by Period

	CADE	ABT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.34%	—
Volatility (6M) Calculated over the trailing 6-month period	—	18.93%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	23.96%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	21.97%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	23.63%	—

Dividends

CADE vs. ABT - Dividend Comparison

CADE's dividend yield for the trailing twelve months is around 2.78%, which matches ABT's 2.80% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABT Abbott Laboratories	2.80%	1.88%	1.95%	1.85%	1.71%	1.28%	1.32%	1.47%	1.55%	1.86%	2.71%	2.14%
CADE Cadence Bancorporation	2.78%	2.57%	2.90%	3.18%	3.57%	7.34%	2.72%	2.26%	2.37%	1.29%	0.00%	0.00%

Financials

CADE vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between Cadence Bancorporation and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CADE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cadence Bancorporation reported a gross profit of 0.00 and revenue of 787.17M. Therefore, the gross margin over that period was 0.0%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.

CADE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cadence Bancorporation reported an operating income of 198.70M and revenue of 787.17M, resulting in an operating margin of 25.2%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.

CADE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cadence Bancorporation reported a net income of 146.75M and revenue of 787.17M, resulting in a net margin of 18.6%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.

Frequently Asked Questions

Can I hold both CADE and ABT in my portfolio?

CADE and ABT have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.